Vinod Pullarkat Selected Research

Bronchiolitis Obliterans Syndrome

1/2014	Nodular regenerative hyperplasia causing portal hypertension in a patient with chronic graft versus host disease: response to sirolimus.
4/2005	Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vinod Pullarkat Research Topics

Disease

32	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 12/2012
30	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 05/2008
12	Leukemia 06/2022 - 08/2011
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 04/2005
10	Neoplasms (Cancer) 10/2020 - 05/2007
9	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 01/2003
8	Philadelphia Chromosome 01/2019 - 05/2008
6	Residual Neoplasm 02/2022 - 11/2007
6	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 02/2008
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 05/2007
4	Infections 01/2020 - 06/2008
4	Iron Overload 01/2020 - 12/2009
3	Hemorrhage 01/2021 - 03/2009
3	Hyperbilirubinemia 12/2020 - 03/2014
3	Neutropenia 01/2020 - 04/2003
3	Thrombocytopenia (Thrombopenia) 01/2020 - 03/2011
3	Venous Thromboembolism 01/2019 - 09/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2017 - 12/2009
2	Pathologic Complete Response 01/2022 - 01/2020
2	Nausea 01/2020 - 06/2008
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019 - 07/2017
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 10/2014
2	Cytopenia 01/2017 - 01/2003
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2016 - 08/2011
2	Systemic Mastocytosis 01/2016 - 10/2014
2	Sickle Cell Anemia (Hemoglobin S Disease) 06/2015 - 01/2014
2	Fibrosis (Cirrhosis) 11/2014 - 01/2003
2	Hyperplasia 11/2014 - 01/2014
2	Bronchiolitis Obliterans Syndrome 01/2014 - 04/2005
2	Anemia 03/2011 - 01/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2011 - 10/2005
1	Water Intoxication 10/2021
1	Hemorrhagic Cystitis 10/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Disease Progression 01/2021
1	Thrombocytosis (Thrombocythemia) 01/2021
1	Colonic Neoplasms (Colon Cancer) 10/2020
1	Febrile Neutropenia 01/2020

Drug/Important Bio-Agent (IBA)

20	venetoclaxIBA 10/2022 - 01/2018
8	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 04/2005
7	Sirolimus (Rapamycin)FDA Link 01/2022 - 02/2010
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2005
6	Azacitidine (5 Azacytidine)FDA Link 10/2022 - 01/2019
6	Inosine Triphosphate (ITP)IBA 01/2021 - 02/2008
5	blinatumomabIBA 11/2022 - 09/2017
5	Tyrosine Kinase InhibitorsIBA 02/2019 - 07/2015
5	IronIBA 06/2016 - 12/2009
4	Decitabine FDA Link 01/2021 - 01/2019
4	Core Binding Factors (Core-Binding Factor)IBA 01/2021 - 12/2012
4	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 10/2005
4	pegaspargase (Oncaspar)FDA Link 01/2019 - 03/2014
3	fludarabineIBA 01/2022 - 01/2014
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 03/2011
3	Busulfan (Busulfex)FDA Link 01/2020 - 02/2010
3	EnzymesIBA 01/2019 - 01/2013
3	Asparaginase (Elspar)FDA Link 01/2018 - 03/2014
3	AutoantibodiesIBA 01/2017 - 01/2003
3	Ferritins (Ferritin)IBA 03/2015 - 01/2010
2	Pharmaceutical PreparationsIBA 06/2022 - 03/2011
2	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2020
2	ruxolitinibIBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2008
2	Dasatinib (BMS 354825)FDA Link 11/2019 - 10/2016
2	AntioxidantsIBA 01/2019 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2014
2	romiplostim FDA Link 02/2015 - 02/2008
2	Reticulin (Reticular Fiber)IBA 11/2014 - 01/2003
2	Deferasirox FDA Link 08/2014 - 01/2013
2	Chelating AgentsIBA 08/2014 - 01/2013
2	Thrombopoietin (c-mpl Ligand)IBA 10/2012 - 01/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2006 - 04/2005
1	Chimeric Antigen ReceptorsIBA 12/2021
1	Mesna (Coenzyme M)FDA LinkGeneric 10/2021
1	AnticoagulantsIBA 01/2021
1	Thrombopoietin ReceptorsIBA 01/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Transaminases (Aminotransferases)IBA 12/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 12/2020
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 10/2020
1	Interleukin-3 (Interleukin 3)IBA 10/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2020
1	Guanosine Triphosphate (GTP)IBA 10/2020
1	Ribosomal RNAIBA 10/2020
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 10/2020
1	fms-Like Tyrosine Kinase 3IBA 07/2020

Therapy/Procedure

30	Therapeutics 10/2022 - 05/2007
26	Cell Transplantation 01/2022 - 11/2006
10	Drug Therapy (Chemotherapy) 11/2022 - 05/2007
8	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2009
5	Transplantation 01/2022 - 06/2008
5	Salvage Therapy 01/2021 - 04/2005
3	Homologous Transplantation 01/2022 - 12/2017
3	Stem Cell Transplantation 12/2017 - 10/2005
2	Lymphatic Irradiation 01/2022 - 04/2017
1	Immunotherapy 12/2021
1	Aftercare (After-Treatment) 01/2020
1	MDC protocol 01/2020